Minister inaugurates Sai Lifesciences' new Research & Technology centre in Hyderabad | Information Technology, Electronics & Communications Department, Government of Telangana, India
  |   Skip to content   |   Custom   Black
| Select Theme:    A+  /  A  /  A-
KCR Photo
Sri K Chandrashekar Rao
Hon'ble Chief Minister
KTR Photo
Sri K T Rama Rao
Hon'ble Minister for IT, Industries, MA & UD
Minister inaugurates Sai Lifesciences’ new Research & Technology centre in Hyderabad
Sai Lifesciences Limited, a growing contract research organisation, today announced the commissioning of its new Research and Technology centre in Hyderabad. The Centre, located in Genome Valley, is spread across 83000 sq ft with several unique features. The new Research & Technology centre is adjoining their current R&D facility in Genome Valley, Hyderabad.

The Centre was inaugurated by Mr. K.T Rama Rao, Hon’ble Minister for Industries, IT, MA & UD, Government of Telangana in the presence of Mr. Jayesh Ranjan, IAS, Principal Secretary, Industries and Commerce and Mr. Shakthi Nagappan, Director (Life Sciences & Pharma) and Chief Executive Officer, Hyderabad Pharma City Ltd, and senior leaders from Sai Lifesciences.

Minister inaugurates Sai Lifesciences’ new Research & Technology centre in Hyderabad

Speaking on the occasion, Hon’ble Minister K.T Rama Rao said, “I’m delighted to inaugurate this world-class Research & Technology Centre of Sai Life Sciences. It is a matter of pride for us that Hyderabad today is emerging as the Innovation hub and serving more than 1000 global innovators in their vision to improve healthcare and Research & Development around the globe. Sai Life Sciences expansion in Hyderabad serves as the testimony to Hyderabad’s growing R&D prowess and extraordinary talent pool. I sincerely congratulate the entire team of Sai Life Sciences, not only for the new Research & Technology Centre but, also for their work towards the development and manufacturing of new life-saving medicines” Krishna Kanumuri, CEO & MD, Sai Lifesciences said, “Our philosophy behind building this new facility was to go beyond what the norm is in India and to create what our global innovator partners expect in their in-house capabilities.” He further added, “We are an example of what is possible in Hyderabad’s rich life sciences ecosystem. Today, as we build world-class R&D capabilities and invest in nurturing talent with deep domain expertise, I can unhesitatingly say, Hyderabad is truly a city where pharma dreams are made”.

Genome Valley is India’s first purpose-built cluster for life sciences R&D. Sai Lifesciences’ new Research & Technology centre is located in the Genome Valley cluster of Hyderabad.

The new Research & Technology Centre aims to be the nerve-centre of the company’s R&D capability and accelerate the discovery and development of new drugs. It has several unique features that set it apart from other R&D labs in the country. The new facility is spread around 83,000 square feet with integral features such as 250 fume hoods, Intelligent lab design, Satellite analytical testing, process safety lab, collaborative works spaces and much more.

Sai Lifesciences works with 7 of the top 10 global innovator pharma companies, and several small and mid-sized innovators. Over the past year, the company has opened new R&D sites in the USA and UK and now, they have expanded in Hyderabad by setting up this state-of-the-art facility in Genome Valley. The vision of the company is to support their global innovator partners to bring 25 new medicines to life by 2025.

Hon’ble Minister K.T Rama Rao also laid the foundation stone for Genopolis- a multi-tenanted laboratory and manufacturing space for Lifesciences and Pharma companies in Genome Valley. Designed to support innovative programs, Genopolis will provide world-class collaborate facilities and infrastructure solutions in an integrated ecosystem to Indian and multinational companies. Genopolis will house the expansion campuses of Yapan bio and Laxai Life Sciences-two world class Contract Research Organisation (CRO) in Genome Valley. Genome Valley Research Platform (GVRP) Private Limited and CoLabs will also be setting up their facility in Genopolis.